MIM
MRAM icon

MetLife Investment Management’s Everspin Technologies MRAM Stock Holding History

MetLife Investment Management’s Portfolio MRAM Stock Details MRAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
+11,530
New +$258K ﹤0.01% 2247

Other funds holding MRAM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MetLife Investment Management's MRAM Position: Q2 2026 in Review

MetLife Investment Management opened a new position in Everspin Technologies (MRAM) in Q2 2026: 11,530 shares worth $279K. The stake represents ﹤0.01% of the portfolio and ranks #2247 among its holdings.

123 funds tracked by Wall St. Rank hold MRAM as of Q2 2026.

  • MetLife Investment Management held 11,530 shares of Everspin Technologies worth $279K as of Q2 2026.
  • Everspin Technologies was a new MetLife Investment Management position in Q2 2026.
  • Everspin Technologies made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2247 holding.
  • 123 funds tracked by Wall St. Rank held Everspin Technologies as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.